Research Articles on Tuberculosis from 1940 onwards

Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
J Affect Disord. 2006 Jul;93(1-3):239-43. Epub 2006 May 4.
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Arch Gen Psychiatry. 2006 Mar;63(3):298-304.
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pyloritreatment: a randomized trial.
Aliment Pharmacol Ther. 2003 Sep 15;18(6):627-33.
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanishmulticenter study of 300 patients.
Am J Gastroenterol. 2008 Jan;103(1):71-6. Epub 2007 Aug 31.
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Drugs. 2003;63(24):2769-802.
Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review?
Curr Ther Res Clin Exp. 2003 Nov; 64(9): 646–661.
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Ther Clin Risk Manag. 2008 Oct; 4(5): 843–853.
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients
High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradig
The safety of levofloxacin in elderly patients on warfarin